Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 1999

View Archived Issues

Incyte and Schering expand agreement

Aventis R&T expands drug discovery collaboration with Nanogen

NeoTherapeutics initiates phase II trial to study effects of Neotrofin on the brain

Pharming awarded grants for human lactoferrin research; announces collaboration

ASBMR participants learn of efficacy, safety of risedronate in several large studies

FDA approves Rochester Medical's FemSoft Insert for female stress urinary incontinence

DuPont, Janssen and Neurocrine Biosciences establish CRF collaboration

Integrin antagonist S-787 prevents ovariectomy-induced bone loss in rats

SmithKline Beecham reports advances in vitronectin receptor antagonist research

Adenosine-dependent cardioprotective effect demonstrated for MX-68

SUN-N4057 reduces both brain and body temperature in cat model of stroke

Preparation and use of dual ETA/ETB antagonists disclosed by BASF

Plant-produced antiangiogenic compound discovered by Phytera

New CRF antagonists codeveloped by Janssen and Neurocrine Biosciences

Novel monoamine reuptake inhibitors designed at ADIR, particularly useful in depression

Novo Nordisk investigates new strategy for diabetes and its complications: normoglycemic agents

Lilly and Synaptic investigate potential of 5-HT1A antagonist in nicotine withdrawal

Nitrate salts of antiulcer agents exhibit improved pharmacological, toxicological profile

Bayer's IL-4 antagonist for asthma enters clinical testing

Potent phenylisoxazoline antimicrobial agents designed at Pharmacia & Upjohn

Scotia seeks approval of Foscan in Europe

Roche confirms AD drug dropped by the wayside; two other MAO-B inhibitors remain in development

Lipopeptide synthesized at Abbott may be therapeutically useful antifungal agent

New class of oxazolidinones with broader spectrum presented at ICAAC by Pharmacia & Upjohn

Bacterial efflux pump inhibitors developed at Microcide and presented at ICAAC meeting

CuraGen and Glaxo Wellcome complete Alzheimer's disease research program

Meiji Seika issues updated product pipeline

rhPM-1 inhibits synovial cell proliferation in vitro, inflammatory cell infiltration in vivo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...